breakthrough opportunity...

Dear Reader,

I want you to take a close look at this:

That’s a screenshot from my personal brokerage account.

As you can see, I currently have $306,380 invested in a single stock.

This stock currently trades for just $13 or so, about the same price as lunch from a fast-food spot.

In other words, this stock is dirt cheap — for now.

Why have I gone in so big on such a tiny little company? Well...

In the months following December 15th 2021, I predict two things will happen…

First, this company could receive full approval on the first ever “Plug and Play” cure for ALL diseases…

And second, this stock could personally hand me over a million dollars in pure profit.

I’m not telling you this to brag.

I simply want to show you how serious I am about this situation…

AND to give you the chance to JOIN ME on this potential profit party, starting TODAY.

So, in the next few minutes, I’ll give you all the urgent details about what this company does…

Including the projected $228 billion market it could soon dominate...

And how, in the future, its groundbreaking cancer treatment has the potential to:

  • Eliminate the need for painful surgeries, sickening chemotherapy or radiation treatments.

  • “Train” your body to not only fight off current cancer cells, but detect any future cancer cells and fight those, too.

  • Be repurposed to fight ANY type of cancer, and eventually… ANY disease!

But before we get to any of that, let’s talk about the potential rewards for YOU when you act now…

In a moment, I’ll show you why I believe this company’s stock could soar anywhere from 404%... to 1,096%!

On the low-end, that’s enough to turn a $5,000 stake into $20,200.

And on the high-end, it’s enough to turn a larger $10,000 starting stake into $109,600.

As for me, with $306,000 of my own money invested, I’m personally looking to turn this into more than a million-dollar profit!

And it could all start to happen as soon as December 15th, just days away.

I’ll explain exactly why in the next few minutes.

Plus, I’ll reveal how YOU can get the name and ticker symbol of this company today.

But first, let me back-up a bit and explain who I am, and how I even found this exciting opportunity…

My Name is Lou Basenese…
and I’m not your average
“Stock-Picking Guru”...

Most people touting stocks online don’t have the cojones to actually put their money where their mouth is…

They’ll tell you to “buy, buy, buy!”...

All while they’re dead-broke and never have the money or guts to invest in their ideas.

Not me.

I’m not your average self-proclaimed “guru.”

I do my own research. I manage my own money. I have massive skin in the game on my ideas…

Which is why I’m telling you upfront:

I have so much conviction in what I’m showing you today, that I’ve put more than $300,000 of my own money into this single stock:

You see, this $13 company operates in one of my favorite sectors. And as an investor, it’s one of the most exciting sectors: biotech!

More specifically, it operates in the bleeding-edge field of cancer treatments...

The Washington Post calls this: “The hottest field in cancer treatments.”

Johns Hopkins said this breakthrough therapy is “an especially welcome change for cancer patients…”

And Harvard Medical School states: “Cancer treatment has been transformed by targeted drugs and the emergence of [this breakthrough]...”

I call this breakthrough “PGB”

And soon it could save your life — or the life of a loved one — while giving you the potential to grow rich at the same time!

I’ll tell you what “PGB” stands for in a moment…

But before I show you everything you need to see, let’s set the stage here:

If you’re reading this special presentation, you may already know me because you’ve subscribed to my Digital Fortunes monthly research service…

Or maybe you’ve seen some of my numerous TV appearances on Fox Business or CNBC

But what most people don’t know about is my obsession with biotech stocks.

Once upon a time, I was on track to go to med school. In fact, before getting a lucrative offer to go work on Wall Street, I was pre-med.

And even though I ended up in finance, I’m still a total nerd for medicine.

Which gives me (and YOU, as a reader of mine) a true “edge” in the markets.

In fact, last year I had what many have called “the most profitable day in financial publishing history...”

When I closed SEVEN straight biotech stock wins in a row — all closed on a single day!

Just take a look…

* Note: These recommendations had been open for just a few months — 3 months and 12 days, to be exact. But I recommended taking profits on them in a single day!

So when it comes to hunting down the most potentially profitable, under-the-radar stocks, I’m the one you want on your side.

And what am I pounding the table on today?

You guessed it: The tiny “Plug and Play” company I have over $300,000 invested in!

Right now, it’s fighting cancer…
Next Up: ALL diseases!

You see, this tiny company is developing a groundbreaking cancer treatment...

One that would eliminate the need for painful, drawn out procedures like surgery, chemotherapy and radiation.

Because this company is a pioneer in a cutting-edge sector of cancer treatments.

Specifically, it’s created something I’m calling “Precision Guided Biologics” — or “PGB” for short.

Now, to understand the full promise of this “plug and play” PGB treatment, we first have to look at the currently available options to treat cancer…

For example, have you ever watched a loved one go through chemo? It’s brutal to watch...

The loss of appetite…

The sores in their mouths…

The constant nausea…

The weight loss, the depression, the constant pain…

And on and on.

That’s because, in an attempt to kill cancer cells, chemotherapy ALSO kills some of your healthy cells.

It’s poison for the entire body.

It seeks to kill every cell — cancerous or healthy. Chemo doesn’t discriminate.

Which is why chemo patients often look even more sick than they looked before starting treatment.

If you’ve witnessed this first hand, you know it’s heartbreaking to see…

And if you haven’t seen it firsthand, well... I hope you never will.

Aside from chemo, there’s also invasive surgery and painful radiation…

And if you’ve witnessed loved ones go through either of those treatments, you know those can be brutal, too.

With surgeries, you’re at the mercy of a doctor’s knife. And while they may “open you up” with the best of intentions…

Oftentimes there are unforeseen consequences…

Internal bleeding, blood clots, or worse.

And with radiation, you’re essentially burning your body in hopes to burn tumorous cells, too.

But today, thanks to this “plug and play” treatment I’m so excited about, there’s hope. Because…

This “PGB” breakthrough cancer treatment essentially “trains” your body’s own immune system
to fight cancer

That’s why the Cleveland Clinic said it’s “an evolving and promising cancer treatment.”

Now, being that this breakthrough is so new, there are NOT a lot of biotechs doing what this tiny $13 company is doing…

But good god, I can tell you this…

The few PGB stocks that ARE in the market have seen enormous returns…

Like Trillium Therapeutics…

Trillium saw its stock spike 188% over the weekend after a massive $2.3 billion buyout offer from Pfizer…

Or take a look at Arcus Biosciences (RCUS)...

After entering a deal with Gilead which valued the company at more than $2 billion…

Its share price soared, handing investors who got ahead of the deal a 528% gain!

And most incredible of all…

A tiny company called Forty Seven, Inc. (FTSV) was acquired by Gilead for $4.9 billion…

Handing early investors a peak gain of 1,605% in less than six months!

All these companies were involved with breakthroughs just like the one I’m showing you here today…

Which is why…

I believe the NEXT big buyout in this sector will be the tiny $13 “Plug and Play” company I’m telling you about today!

To show you exactly why I’m so confident, let me explain how its groundbreaking treatment works, in its most basic form…

Remember, PGB stands for “Precision Guided Biologics.”

Let’s start with the “biologics” part of things…

This company develops drugs using what’s called living, biological proteins…

It injects these inside the patient through an IV.

Once inside the body, these drugs — or “biologics” as they’re called — activate the patient’s own immune cells to attack the deadly cancer cells.

Meaning NO chemo…

NO radiation…

And NO surgery.

Just your OWN immune system boosted by these drugs!

And by harnessing the power of your body’s natural immune system like this…

This treatment has the potential not only to attack and kill current cancer cells…

But to detect any future cancer cells that might appear.

Meaning it’s not only a treatment, but a potential prevention tool as well.

So it’s no wonder that research firm Reports and Data projects this industry to be worth $228 billion in the coming years.

And it’s no surprise that CNBC reported: “Investors are betting on a cancer cure with these… stocks”

Fortune stated: “‘Miracle’ cancer treatments could be a blessing for investors too”

And a Seeking Alpha article even called this breakthrough “The Holy Grail of Cancer Treatment.”

But they’re all missing the most promising story of all…

I’m referring, of course, to the tiny $13 per share company I’m telling you about today!

The same one that could hand fast-movers a potential 404% gain on the low end… and 1,096% on the high end!

A true “ten-bagger.”

I’ll show you more about those profit projections in just a minute…

Including the most exciting part about this company’s breakthrough…

How its treatment could easily expand to cover ALL diseases.

But for now, understand this:

The simple fact that this company is flying under-the-radar…

Is GREAT news for us!

For Now, This Tiny Company is Flying Completely
Under-the-Radar...

But by December 15th, It Could Be ALL Over the News!

Now, you might be thinking:

If this company’s treatment is so good…

Why isn’t it all over the news already?

Why isn’t it treating every cancer patient with its drugs?

Well for one thing, as I’ve been saying…

This company is TINY. In fact, it’s what’s known as a micro-cap stock.

Its market cap is only around $400 million.

As a comparison, look at a massive company you already know, like Amazon…

Amazon has a market cap of over $1.7 TRILLION.

Meaning this tiny company is more than 4,000 times smaller than Amazon!

And when it comes to tiny companies like this, you simply WON’T hear about them until it’s too late.

Because they’re rarely covered by analysts, and you certainly won’t see them all over the news.

Investopedia even stated that small stocks like micro caps “often have very little analyst coverage and garner little to no attention from Wall Street. That makes them undervalued and gives them higher returns.”

Another reason you likely haven’t heard a peep about this company is a little more obvious…

It’s an early-stage biotech company, with its treatment currently only in the first phase of clinical trials.

But I predict it could reveal BREAKTHROUGH data on December 15th…

And once it does…

It could quickly get scooped up for billions of dollars by a Big Pharma company like Pfizer, Gilead, or Merck…

In fact, as you’ll see in a minute, they already have a partnership with Merck!

But the point is, this buyout could hand early investors a real shot at huge gains...

Just like we saw happen with the quick 188% gain on Trillium…

The 528% gain from Arcus…

And the incredible 1,605% gain from Forty Seven, Inc.

In fact, if it does reveal positive results in its clinical trials, I believe we have an amazing chance to see a massive buyout offer.

As I’ll show you in a minute, that’s just how these early-stage biotech companies work.

First though, I need to explain what makes this company’s treatments so attractive…

“Plug and Play” to Treat Cancer...

Now, as good as the gains have been from similar companies in this “PGB” cancer-research space…

Fact is, this tiny company’s treatment stands head and shoulders above the rest...

Remember, this treatment activates your own immune cells to fight off cancer cells.

That was the “biologics” part of “Precision Guided Biologics.”

Now let me explain what I mean by the “precision guided” part...

See, most other treatments in this space have no way of telling immune cells exactly which other cells are cancerous, and which cells are healthy.

So — like chemotherapy — your immune system also attacks your healthy cells, leading to some potentially nasty side effects.

But this company managed to develop a way to “train” immune cells to ONLY target cancerous cells.

Here’s an easy way to understand it:

Think of typical cancer treatments like chemo as a “carpet bomb” approach…

As I told you earlier, chemo treatments end up scorching nearly everything in their path.

But with the company I’m telling you about today...

Its treatment is more like a precision guided missile.

Attacking ONLY what you want it to attack.

*** In this case, only the cancer cells. ***

Which is exactly why I call this breakthrough “Precision Guided Biologics” or “PGB.”

Mark My Words: PGB will be worth a FORTUNE in the coming years…

Currently, this tiny company is testing its drugs on Human Papilloma Virus, or HPV-based cancers.

Now, HPV affects over 79 million Americans...

And over 630,000 cases of HPV lead to cancer each year globally.

In fact, nearly 10% of ALL cancer diagnoses worldwide are believed to stem from HPV.

So no wonder Grandview Research estimates the global HPV treatment market size to be worth over $16 billion.

If our tiny $400 million market-cap company continues to show the efficacy of its drugs…

And even if it manages to capture only 10% of that market…

It would be looking at a 300% revenue increase from HPV treatments alone!

But here’s the thing…

As you’re about to see, because of its “Plug and Play” drug platform, its treatment could go well beyond just HPV cancers…

In fact, if we back up and look at the cancer treatment market as a whole…

Which is projected to be worth over $469 billion…

Fact is, if our tiny company captures 10% of the entire cancer treatment market — just $46.9 billion worth...

This tiny company could be looking at a growth surge of over 11,625%!

But here’s the absolute best part about this tiny company:

Due to the “modular framework” it’s built into its treatment...

Once it proves it can treat cancer this way…

It can simply “plug in” a way to cure ANY disease.

Meaning faster, cheaper, and more effective treatments than anything out there…

AND the possibility to become the most valuable biotech company EVER!

“Plug and Play” to Cure
ANY Disease!

Let me show you what this means…

Your immune system works to fight cancer through the communication between two different cells…

“T-Cells” and “Antigen Producing Cells” or APCs.

The T Cells are the actual cells that will go out, replicate, and kill dangerous cells like cancer.

Which is why The University of Cambridge called T Cells, “The Cancer Assassin.”

But to be an assassin, these T Cells need to be given orders.

Unfortunately, most treatments in this space involve telling ALL the T Cells to kill, hoping they’ll get the right target.

Making them liable to attack not only cancer cells… but healthy cells too.

Simply put, they have no way of knowing exactly which cells to kill.

And THAT’S where our tiny company comes in...

Because it’s created a drug framework that “mimics” the cells that activate and guide cancer-killing T Cells…

Essentially, it’s found a way to give T Cells a “hit list”!

This way, it ensures they’re ONLY activating cancer-killing T Cells, and ONLY attacking cancer cells, like a precision-guided missile!

And with this framework, they can easily hand the T Cells a new “hit list” to target ANY disease they want!

Meaning, this company can essentially “plug and play” new targets into its framework to potentially cure ANY disease!

From Rheumatoid Arthritis… To Type 1 Diabetes… The Flu… And Even HIV... This Company’s Treatment Could Fight Them All!

Let’s focus on diabetes for a moment…

This is a debilitating and potentially deadly autoimmune disease.

And it’s estimated that over 463 million people have been diagnosed with it.

And in the coming years, that number shows NO signs of slowing down:

Currently, there’s no cure for it.

But as we speak, this tiny $13 per share company is testing its “plug and play” approach to stop Type-1 diabetes in its tracks!

According to GrandView Research, the current market size for diabetes treatments is $28.5 billion in 2021.

Even if our $400 million market cap company’s drug captures just 10% of that market…

We’d be looking at another 612% revenue surge from this tiny company if its diabetes platform is approved!

The same goes for Rheumatoid Arthritis, another autoimmune disease affecting 14 million people…

With a projected drug-market size of over $62 billion!

Just 10% of that would hand our company a revenue surge over 1,400%!

And take HIV, the disease that leads to AIDS.

Nearly 40 million people across the globe currently have it, and there’s no cure.

Furthermore, since 1981, nearly 40 million people have died from it

But with this company’s “Plug and Play” breakthrough…

It could very well roll-out treatments into its FDA approval pipeline as easily as you’d change your shoes…

Potentially grabbing a share of the projected $36 billion HIV drug market.

I think you get the picture here: starting with fighting cancer, and then expanding into all disease, this company’s revenue could SOAR!

There aren’t enough days in the week to cover everything it could potentially cure…

In short, with this “Plug and Play” approach, this company has the potential to do this over and over again, with all types of infectious and autoimmune diseases…

Like…

The list goes on and on...

And very soon, I expect this company to announce groundbreaking results in its current cancer trials.

This could lead to full FDA approval…

A BIG potential buyout offer…

And send its stock price soaring!

Why You Should Circle
December 15th, 2021
on Your Calendar

As I mentioned before, this company is in early stage clinical trials with real patients…

And so far, the results have been phenomenal.

According to my research, I believe this company will release new data for this current trial on or around December 15th, 2021.

And when it does...

I expect its share price to go through the roof.

I believe the data it will reveal will launch this tiny company directly onto the “buy” lists of big Wall Street investment firms...

As well as onto Big Pharma’s radar as well.

Now, to be clear…

I have no “inside information” on this company. I’m simply an independent analyst doing my own research, and then presenting all my findings to you today.

As the saying goes, I’ve “dotted all the i’s” and “crossed all the t’s.” But I could still be wrong.

That said, just look at the clues here:

I mean, this company is already on Big Pharma’s radar as we speak…

Striking not one, but two partnerships...

One with $211 billion pharma company Merck, and the other with LG Chem, the largest Korean chemical company!

Fact is, a potential billion-dollar buyout for this tiny company…

Which could happen any day...

Could hand anyone who gets in right now an absolute fortune.

If recent deals in the sector are any clue…

We could see potential gains of
404%... 510%... even 1,096%
thanks to this groundbreaking
 news!

For instance…

Remember Arcus Biopharma that I mentioned earlier?

After it entered into a deal with Gilead Sciences…

Analysts valued Arcus at $2 billion.

A similar deal with our tiny company would value the stock at over $65 a share...

That would add up to a 404% gain from where it trades now!

And consider what happened when pharma giant Sanofi bought out tiny biotech firm Synthorox for $2.5 billion…

If our tiny company gets a $2.5 billion buyout deal like it did…

It would be valued at $79 a share.

An incredible 510% gain from where it is right now!

And now take a look at Forty Seven, Inc.

This is another biotech company I mentioned earlier.

Also working on groundbreaking cancer drugs…

Gilead Sciences scooped this one up for around $4.9 billion.

If that happens to our tiny $13 stock…

Its share price would rocket to $155!

A 1,096% increase!

Look...

If we manage to see gains like that…

You put $1,000 into this tiny stock — and 1,096% turns it into $10,960.

You put in $10,000 — you’d be looking at $109,600.

And if you were to put in $100,000…

You’d be sitting on a million-dollar fortune.

Please understand though...

This is the BEST-case scenario.

And it would likely play out over a longer time frame.

*** ALL investing carries risk. And tiny micro-caps like this one carry even more risk than usual. ***

But...

All my research points to significant upside for this tiny stock.

Which is exactly why I have over $306,000 of my own money invested in it right now.

Of course, I’d NEVER suggest you invest as much as I have…

But as you can see, even a small stake here has the potential to hand you a hefty payday.

As long as you get in RIGHT NOW...

While this company is still cheap and flying under the radar.

By December 15th, that could all change…

And the biggest potential gains could be off the table.

In fact, our window of time to act could be even smaller than that.

Because it could realistically release its game-changing data any day now.

Immediately triggering a buyout offer from any one of the giant pharmaceutical companies.

Meaning, to make the most potential money from this stock…

The best time to act was yesterday...

But the second-best time to act is NOW! While this company is still cheap and still flying under-the-radar…

The truth is, you have a very short window of time to act on this opportunity today.

And if you’ve made it this far...

I want to make sure you have everything you need to get “in” alongside me.

You see, I’ve been knee-deep in research on this company for over two years…

I invested in it myself shortly after its IPO…

And I slowly increased my stake in it as it’s continued to prove how well its “Plug and Play” cure works.

To the point where I have $306,380 invested in it right now.

That makes it the largest single stock position I own.

So I’ve gone ahead and compiled ALL my research on this company into a single report called…

“The ‘Plug and Play’ Cure: Biotech’s Next Billion-Dollar Buyout.”

This report will give you absolutely everything you need to jump on this opportunity right away, if you choose.

Inside, you’ll find:

  • Everything I’ve uncovered over the years boiled down into simple, easy-to-understand language.

  • Including how more than $50 million in government funding has already gone into developing its technology at the Albert Einstein College of Medicine.

  • How it’s already landed not one, but two strategic deals with Merck and LG Chem. Meaning there’s an even greater chance we’ll see a buyout any day now.

  • And every other reason why the risk in this investment is significantly lower than usual.

I’ve done all the “heavy lifting” for you in this report…

All the due diligence you could possibly want boiled down into one easy-to-read report.

But because I’m so serious about this specific company, I’m going even further, to lengths you won’t find anywhere else!

So…

You’ll also get a full “due diligence” video breakdown, where I lay out the entire case for this tiny company on camera…

All the research I’ve done over the years…

All the science behind its breakthrough…

As well as my specific profit projections, and specific “buy up to” guidance for this pick…

Everything is included inside this special video breakdown.

This way, if you want, you can read all my research in the “Plug and Play Cure” report AND watch my full presentation.

Now, look, I’ve said it before, and I’ll repeat it again now so it’s crystal clear:

*** Everything you’ve seen here today is my best-case prediction. Although my track record is stellar, past performance doesn’t guarantee future gains. I could get this one wrong. So please, do not invest more than you can afford to lose in this play — or in ANY play.

But, if you’re serious… and if you go into this situation “eyes wide open,” knowing the risk AND the potential rewards…

Then the only thing you have to do is claim your full report today, open it up, read it…

Watch the video…

Learn the name, ticker, and all the research I’ve prepared…

And buy into this company before any potential breakthrough is announced.

But before I show you how to do all that, I have to be clear about something else, too...

I CANNOT Send this Research Package to Everyone

Like I said, this company is TINY.

Over 4,000 times smaller than Amazon.

Its stock price is currently under $13, with a market cap of around $400 million.

So if I send this report and video breakdown to everyone viewing this page today...

And they all rush in to buy at once…

It would artificially inflate the price.

Think of it like this:

And so…

Because I don’t want this tiny stock to “overflow”...

I can only send this package to a limited number of readers today.

Specifically, I’m only sending it to readers who decide to join me in a research service I’ve developed...

Introducing Micro-Cap Advantage

Micro-Cap Advantage has one purpose: To hunt down the most potentially explosive micro-caps on the market.

Every month, I send readers of Micro-Cap Advantage a brand-new, tiny stock to act on…

One that could potentially multiply your investment many times over.

I’m constantly digging deep into SEC filings, scouring earnings reports, even regularly hopping on the phone with company executives to hand you the most compelling, up-to-date info I possibly can.

This is the type of research big Wall Street institutions would pay out the nose for…

But don’t worry…

Because you won’t have to pay “Wall Street prices” to get this information.

Plus, I always make sure that everything I send you isn’t complicated or bogged down with technical jargon.

And just to be completely transparent about my track record...

Take a look at this snapshot of my full model portfolio for Micro-Cap Advantage since inception:

As you can see for yourself, triple-digit gains are pretty common in Micro-Cap Advantage

But I believe these past gains pale in comparison to the FUTURE gains we could see from the tiny “Plug and Play” cure company I’ve been telling you about today.

Which is why, when you agree to join Micro-Cap Advantage today…

I’ll immediately send you my special research report on this company, “The ‘Plug and Play’ Cure: Biotech’s Next Billion-Dollar Buyout.”

PLUS the in-depth video breakdown I’ve recorded, too!

It’s yours as a FREE bonus just for joining me in Micro-Cap Advantage.

But remember, like I said…

I just can’t send this report out to too many people today.

So through this specific page…
I can only let in 50 New Micro-Cap Advantage members today

Once those spots are filled… that’s it.

I simply must keep membership extremely limited, so I don’t risk running up the stock price.

In fact, to make sure that doesn’t happen, I’ll be closely monitoring its price.

And I reserve the right to close the doors here at ANY minute!

The good news… and I can’t guarantee this…

But if everything looks ok, I might open the doors to more people tomorrow.

But DON’T quote me on that.

For today, I’m keeping a strict limit of 50 new members.

If you pass this up today...

Your chance to grab my research, and secure your spot in Micro-Cap Advantage will be gone. Possibly for good.

Considering this message is being sent to over 55,000 readers right now…

I can only let in .09% of my entire readership today. That’s less than one-tenth of one percent.

But, if you’re fast enough to snag a membership…

I’ll make it completely worth your while...

By sending you a number of EXTRA bonuses along with your new subscription…

BONUS Gift #1: The Micro-Cap Millionaire
Playbook: 2021 Edition

If you secure one of the 50 spots available today, I’ll immediately rush you your “Plug & Play Cure” research package.

But, as an additional free BONUS, I’ll also rush you a copy of a report that will be invaluable to you as a Micro-Cap Advantage member…

It’s called The Micro-Cap Millionaire Playbook.

In this report, you’ll find everything you need to get started investing in micro-cap stocks on your own.

Including why micro-caps have consistently outperformed larger companies…

Why micro-caps are the only area of the stock market where “the little guy” has a true edge against Wall Street…

How micro-caps can be the #1 asset to buy in the middle of a crisis…

And my full 5-step filtering system for hunting down the best micro-caps to invest in. (The same system I personally use to find micro-caps for myself.)

This report has everything I learned from hunting down micro-caps on Wall Street AND everything I’ve learned investing in them on my own over the past 20 years.

This information is what’s allowed me to attain the kind of wealth most people only dream of…

To the point where I can invest over $300,000 in a single play.

So it’s not difficult to see the amount of value I’ve packed into this report.

But you won’t have to spend 20 years or six figures to get it.

Because you’ve agreed to take a spot in Micro-Cap Advantage today, it’s all yours, FREE.

But to make your decision even easier, I’m prepared to sweeten the deal even more...

BONUS Gift #2: The 3 Pillars To Safely Making a Fortune in Micro-Caps

As you know by now, micro-caps are TINY stocks.

And when you invest in them, you’re agreeing to back an early stage company.

An investment like this comes with more risk than you’d see with larger, more established companies.

But all companies need to start somewhere! After all, even Amazon, Microsoft and Google started as micro-caps!

The trick to finding the next giants of tomorrow is to be disciplined about investing in these micro-caps.

Which is why I’ve put together a report I consider 100% essential to any Micro-Cap Advantage member.

I call it The 3 Pillars to Safely Making a Fortune in Micro-Caps.

You’ll see exactly what I recommend you do whether you’re a seasoned pro investor, or a newbie.

Because with this report, I’ll show you exactly how to maximize your gains with micro-caps, while ALSO slashing your risk to the bone.

In fact, I’ll show you a way to try out micro-cap investing for yourself with ZERO risk!

When you subscribe today, you’ll get your first bonus report, The Micro-Cap Millionaires Playbook AND The 3 Pillars to Safely Making a Fortune in Micro-Caps both completely FREE. As my gift to you as a new subscriber.

But that’s not all...

BONUS Gift #3: How To Instantly “Boost” Your Micro-Cap Advantage Profits By 37%

The “Plug & Play Cure” Company I’ll tell you about in your free research package has the potential to change your life…

Your Micro-Cap Millionaire Playbook will become invaluable to you…

And the 3 Pillars Guide to cutting risk while maxing gains will be YOUR edge that no one else has.

But I’ll throw in another valuable bonus, FREE, when you subscribe today…

In short, it’s a unique way to “boost” any profits you might make with micro-caps… by up to 37%!

It’s dead-simple, and absolutely essential if you’re looking to lock in maximum gains.

And you’ll discover the secret in the 3rd bonus I’m prepared to send your way for free when you subscribe today.

The guide is called How To Instantly “Boost” Your Micro-Cap Advantage Profits By 37%

And as long as you’re one of the first 50 people who respond to this message today…

It’s all yours. FREE.

When You’re One Of The First 50 People to Act Right Now… Here’s Everything You’ll Get Today:

Just to summarize…

When you act today, if you manage to be one of the first 50 people to do so…

Here’s everything you’ll get:

  • 12 Months of Micro-Cap Advantage — That’s at least one new micro-cap stock sent straight to your inbox each month. With my full research and write up, the name and ticker of each company, the buy-up-to price, everything. This is institutional-level research boiled down into easy-to-act-on terms, all for you.

  • Flash Action Alerts — Whenever I have a new buy and sell alert, you’ll be notified ASAP by email. This way, you’ll know what to get into — and exactly when to get out of — any positions and take some potential profits!

  • Micro-Cap Advantage Members-Only Model Portfolio — You’ll be provided with a secure login, unique to you, that you can use to view all your Micro-Cap Advantage issues, bonus reports, and the special Model Portfolio where you can view all our open positions.

  • The “Plug & Play Cure:” Biotech’s Next Billion-Dollar Buyout — This research report includes my full research into the one tiny company pioneering a cancer treatment, and eventually, a potential cure for ANY disease. This is the same company I’ve invested over $306,000 into. You’ll want to act immediately on this one. Because remember, by December 15th, its stock price could start to skyrocket!

  • “Due Diligence” Video Breakdown — In addition to the “Plug and Play Cure” Report, I’ve recorded a video going over ALL my research in depth. This will ensure you have absolutely every bit of information you need. That way, if you choose to, you can act on this opportunity right away.

  • FREE Bonus Gift #1: The Micro-Cap Millionaire Playbook: 2021 Edition — This guide will tell you everything you’ll want to know about micro-caps. What they are, how they can help you beat the market, and even how they can be the best place for your money after a crisis.

  • FREE Bonus Gift #2: The 3 Pillars To Safely Making a Fortune in Micro-Caps — Micro-Caps can be risky. So to slash that risk to the bone (and MAXIMIZE your potential gains) there are 3 things every smart investor should do. You’ll see those and more in this report.

  • FREE Bonus Gift #3: How To Instantly “Boost” Your Micro-Cap Advantage Profits By 37% — This report will reveal a simple trick to ensure you get every penny out of any micro-caps you invest in.

All of this is yours as soon as you act today.

And as you can see, I’ve jam-packed as much value as I could into this limited offer.

So even if I charged $10,000, it would be a steal.

But you won’t pay $10,000 today…

You won’t even pay the full “sticker” price of $5,000.

Instead, you’ll get everything you see above...

For a Single Payment of $995!

For just one single payment of $995 today (which is 80% off the sticker price)...

You’ll get 12 new micro-cap opportunities hand-delivered to you monthly, packed with ALL my research into each issue.

You’ll also get flash-email alerts…

Access to my model portfolio…

My full research into the tiny “Plug & Play Cure” company that I have $306,380 invested in right now (Video AND Report format)…

Plus 3 FREE bonus gifts you’ll NEED on your side if you really want to invest in micro-caps seriously.

Now, I’ve told you I can only let in 50 new members today.

If I let in more than that, we risk artificially inflating the stock price on the “Plug & Play” company I’ve been telling you about.

And I DON’T want that to happen.

So with all that in mind, you know these spots will go fast.

Especially considering that this tiny company could release its groundbreaking cancer trial data any day…

Prompting a huge buyout offer from big pharma…

And potentially sending shares skyrocketing.

Clearly, you’ll want to move FAST here.

So...

Here’s What to Do Right Now…

To lock-in your chance to claim one of the 50 spots I’ve reserved today…

Click the big SUBSCRIBE NOW button below:

You’ll be taken to a secure order form where you can review your order, and fill in your billing info.

Then, once you subscribe, and you’ve locked in your spot, you’ll get an email from me with links to everything I’ve promised today.

Now, if you’ve made it this far, you and I both know you’re interested in this opportunity…

And you really have just two choices in front of you right now:

One, you could give up now, “x” out of this page and move on with your life.

Even though I’ve shown you how I have $306,380 invested in this tiny company…

A biotech company that could provide the world with the most groundbreaking cancer treatment we’ve ever seen…

And could possibly expand its technology to cure ANY disease…

Handing anyone who invests in its stock right now a potential fortune in the months ahead.

Or, you have a second choice…

A choice that makes WAY more sense to me:

Take what I’ve shown you in this presentation and do something with it.

Do what most people WON’T do.

Take action today, and potentially change your future.

All you need to do is click the button below to get started.

And just in case you’re still here, and still hesitating…

Let me make your decision even easier than I already have.

Because...

There’s One More Thing
I Want to Do For You…

Listen, I’m not just trying to take your money and run.

I’m fully confident in my picks and my research.

So much so, that once you’re in the doors, I believe you’ll want to stick around as long as possible.

But, if you decide not to stick around...

I’ll give you a full refund within the first 30 days of your subscription.

That’s right. You’ll have a FULL 30 DAYS to try out my research and see if it’s right for you.

If it’s not right for you, even if you just don’t like the design of my issues or emails, just call us up and you’ll get a full refund of what you paid today.

I want to make this decision as easy as possible for you.

But, like I’ve been saying, you’ll want to make your decision fast...

Act Now While You Still Can

You’ve seen everything:

How promising this tiny company is…

My value-packed offer for only $995…

All backed by my 30-day full refund guarantee.

And you know I can only let in 50 new subscribers today.

So make sure to decide as soon as possible.

Because these spots will go fast.

And once they fill up today, that’s it.

I can’t guarantee I’ll open up others.

Click SUBSCRIBE NOW below to get started right away.

Thank you very much for taking the time to read this today.

Ahead of the tape,


Lou Basenese
Founder and Chief Investment Strategist
Micro-Cap Advantage

P.S. This tiny company is pioneering a “Precision-Guided Biologics” cancer treatment…

One that could potentially expand to treat ANY disease with a simple “Plug & Play” mechanism.

And on December 15th, which is just days away…

It could reveal groundbreaking new data in its current cancer trials.

And that could launch this company straight onto the “buy” lists of Big Pharma and big Wall Street investment firms…

Sending its share price SKYROCKETING.

This could be a true “ten-bagger” opportunity.

So act now before you potentially miss out!

Claim one of the 50 spots I’ve made available in Micro-Cap Advantage today to get ALL my research on this company right away.

Simply click SUBSCRIBE NOW below to lock in your spot!

P.P.S. Remember this screenshot from my brokerage account that I showed you earlier?

Well, you may have noticed that this tiny stock isn’t the only stock I’ve invested six figures in…

In fact, if you look at the top line from this screenshot…

You’ll see I have $151,498 invested in ANOTHER tiny stock!

Take a look:

This one currently trades around $21 per share.

And its market cap is only around $500 million, which is much, much smaller than companies like Amazon.

But according to my research, this company could soon start getting paid a “royalty” for nearly every single piece of electronic equipment produced from here on out!

Considering that the number of electronic devices is consistently growing by the tens of billions…

That would be a near never-ending stream of cash!

You see, this tiny company has developed a breakthrough technology that stands to profit from the $500 billion per year semiconductor industry.

If you don’t know exactly what a semiconductor is, just understand this…

It’s in nearly every single electronic device we use today.

And right now, the semiconductor industry is red hot, with NO signs of slowing down.

Since last year, the industry as a whole has tripled in value!

And thanks to this tiny company’s semiconductor breakthrough…

The biggest semiconductor manufacturers in the world will be banging down its door to license its technology.

Which means it could get a royalty payment for every single semiconductor made using its tech!

And could give anyone who invests in it a realistic shot at DOUBLING their money as this tiny company rakes it in!

And a double is on the low end.

On the high end, I’m predicting this tiny stock could hand fast-moving investors over 5 times their money!

Specifically, I’m predicting a return of 487%.

That’s enough to turn $1,000 into $4,870…

$10,000 into $48,700...

And that $150,000 I’ve personally invested into over $730,000!

Of course, that’s my best-case scenario, and to be clear, I don’t think it’ll spike a full 487% in an instant…

But I’m confident it could at least double — very quickly.

So, in addition to all the extra bonuses I’m planning to send your way when you subscribe to Micro-Cap Advantage today…

I’ll ALSO send you another report detailing everything you need to know about this company, free of charge.

I’ll break down its technology, the current big-tech partnerships it already has, its ticker symbol, “buy up to” guidance, everything.

But only if you’re one of the first 50 people to take me up on this offer today.

Just click SUBSCRIBE NOW below to get this surprise bonus report… every other bonus I’ve promised you today....

Along with a full 12-month subscription to Micro-Cap Advantage.